Works matching IS 00070920 AND DT 2009 AND VI 101 AND IP 11

Results: 19

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy.

Published in:

2009

By:

Griggs, J.;
Zinkewich-Peotti, K.

Publication type:

journal article

Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI.

Published in:

2009

By:

Minowa, T.;
Kawano, K.;
Kuribayashi, H.;
Shiraishi, K.;
Sugino, T.;
Hattori, Y.;
Yokoyama, M.;
Maitani, Y.

Publication type:

journal article

Brain metastases admissions in Sweden between 1987 and 2006.

Published in:

2009

By:

Smedby, K. E.;
Brandt, L.;
Bäcklund, M. L.;
Blomqvist, P.;
Bäcklund, M L

Publication type:

journal article

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.

Published in:

2009

By:

Wagner, A. D.;
Buechner-Steudel, P.;
Moehler, M.;
Schmalenberg, H.;
Behrens, R.;
Fahlke, J.;
Wein, A.;
Behl, S.;
Kuss, O.;
Kleber, G.;
Fleig, W. E.

Publication type:

journal article

A prospective study of lifetime physical activity and prostate cancer incidence and mortality.

Published in:

2009

By:

Orsini, N.;
Bellocco, R.;
Bottai, M.;
Pagano, M.;
Andersson, S.-O.;
Johansson, J.-E.;
Giovannucci, E.;
Wolk, A.

Publication type:

journal article

Geographical and temporal distribution of cancer survival in teenagers and young adults in England.

Published in:

2009

By:

Geraci, M.;
Eden, T. O. B.;
Alston, R. D.;
Moran, A.;
Arora, R. S.;
Birch, J. M.

Publication type:

journal article

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.

Published in:

2009

By:

Darby, S.;
Murphy, T.;
Thomas, H.;
Robson, C. N.;
Leung, H. Y.;
Mathers, M. E.;
Gnanapragasam, V. J.

Publication type:

journal article

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.

Published in:

2009

By:

Cleton-Jansen, A.-M.;
Anninga, J. K.;
Briaire-de Bruijn, I. H.;
Romeo, S.;
Oosting, J.;
Egeler, R. M.;
Gelderblom, H.;
Taminiau, A. H. M.;
Hogendoorn, P. C. W.

Publication type:

journal article

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.

Published in:

2009

By:

Perez-Gracia, J. L.;
Prior, C.;
Guillén-Grima, F.;
Segura, V.;
Gonzalez, A.;
Panizo, A.;
Melero, I.;
Grande-Pulido, E.;
Gurpide, A.;
Gil-Bazo, I.;
Calvo, A.;
Guillén-Grima, F

Publication type:

journal article

Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Published in:

2009

By:

Bordoni, A.;
Probst-Hensch, N. M.;
Mazzucchelli, L.;
Spitale, A.

Publication type:

journal article

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients.

Published in:

2009

By:

Mego, M.;
De Giorgi, U.;
Broglio, K.;
Dawood, S.;
Valero, V.;
Andreopoulou, E.;
Handy, B.;
Reuben, J. M.;
Cristofanilli, M.

Publication type:

journal article

Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.

Published in:

2009

By:

Prencipe, M.;
Fitzpatrick, P.;
Gorman, S.;
Mosetto, M.;
Klinger, R.;
Furlong, F.;
Harrison, M.;
O'Connor, D.;
Roninson, I. B.;
O'Sullivan, J.;
McCann, A.;
Tosetto, M

Publication type:

journal article

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study.

Published in:

2009

By:

Wilkowski, R.;
Boeck, S.;
Ostermaier, S.;
Sauer, R.;
Herbst, M.;
Fietkau, R.;
Flentje, M.;
Miethe, S.;
Boettcher, H. D.;
Scholten, T.;
Bruns, C. J.;
Rau, H. G.;
Hinke, A.;
Heinemann, V.

Publication type:

journal article

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.

Published in:

2009

By:

Heijnsdijk, E. A. M.;
der Kinderen, A.;
Wever, E. M.;
Draisma, G.;
Roobol, M. J.;
de Koning, H. J.

Publication type:

journal article

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.

Published in:

2009

By:

van Agthoven, T.;
Sieuwerts, A. M.;
Veldscholte, J.;
Meijer-van Gelder, M. E.;
Smid, M.;
Brinkman, A.;
den Dekker, A. T.;
Leroy, I. M.;
van IJcken, W. F. J.;
Sleijfer, S.;
Foekens, J. A.;
Dorssers, L. C. J.

Publication type:

journal article

Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006.

Published in:

2009

By:

Fairley, L.;
Baker, M.;
Whiteway, J.;
Cross, W.;
Forman, D.

Publication type:

journal article

A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.

Published in:

2009

By:

Lee, C. P.;
Payne, G. S.;
Oregioni, A.;
Ruddle, R.;
Tan, S.;
Raynaud, F. I.;
Eaton, D.;
Campbell, M. J.;
Cross, K.;
Halbert, G.;
Tracy, M.;
McNamara, J.;
Seddon, B.;
Leach, M. O.;
Workman, P.;
Judson, I.

Publication type:

journal article

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.

Published in:

2009

By:

Jernström, H.;
Bågeman, E.;
Rose, C.;
Jönsson, P.-E.;
Ingvar, C.;
Jernström, H;
Bågeman, E;
Jönsson, P-E

Publication type:

journal article

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

Published in:

2009

By:

Alì, G.;
Boldrini, L.;
Lucchi, M.;
Picchi, A.;
Dell'Omodarme, M.;
Prati, M C.;
Mussi, A.;
Corsi, V.;
Fontanini, G.;
Alì, G

Publication type:

journal article